← k3vl4r
Log inGet started →

AKBA (Akebia Therapeutics Inc) Price Forecast

AI-generated price forecast for Akebia Therapeutics Inc (AKBA) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of August 2026: K3vl4r's AI model currently reads AKBA as 2/2 bullish · strong across its horizons (2 of 2 timeframes pointing up), with a last price of 0.8518. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

0.8518

AI outlook

2/2 bullish · STRONG

Timeframes up

2 / 2

Share𝕏PostTelegram

AKBA forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~6 weeks out———
Daily~4 months out▲ Up+112.46%—
Weekly~1.9 years out▲ Up+83.56%—

Latest AKBA news

From the market-news feed the forecasts are read against.

  • Leerink Partners Downgrades Akebia Therapeutics to Market Perform, Announces $1 Price Target · Benzinga · Aug 7
  • Akebia Therapeutics Inc (AKBA) (Q2 2026) Earnings Call Highlights: Vafseo Surges 60% as VOICE ... · GuruFocus.com · Aug 6
  • Akebia Therapeutics (NASDAQ:AKBA) Slides 24.6% Despite Q2 Earnings Beat · ChartMill · Aug 5
  • Akebia Therapeutics, Inc. (AKBA) Q2 2026 Earnings Call Transcript · SeekingAlpha · Aug 5
  • Akebia Therapeutics (AKBA) Reports Q2 Loss, Lags Revenue Estimates · Zacks · Aug 5

🔒

See the full AKBA forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

AKBA forecast — frequently asked

Will AKBA go up?

K3vl4r's AI model currently reads AKBA as 2/2 bullish · STRONG — 2 of 2 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the AKBA price prediction for 2026?

K3vl4r's model projects AKBA toward $0.8581 over the next ~4 months, a +1.1% move from $0.8486. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could AKBA reach?

Over its longest horizon (~~1.9 years), the model's projected target for AKBA is $0.8640 (+0.8% vs $0.8568). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

STTKHALOMLTXEWTXPACSEOLSWGSPCVXHYPDCELCACRVSNDARVMDPGEN

Will AKBA reach…?

Will AKBA reach $1.00?Will AKBA reach $2.00?Will AKBA reach $3.00?Will AKBA reach $5.00?

Or see the full AKBA price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare AKBA

AKBA vs STTKAKBA vs HALOAKBA vs MLTXAKBA vs EWTXAKBA vs PACSAKBA vs EOLS

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.